SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana.
Identifieur interne : 000C31 ( Main/Exploration ); précédent : 000C30; suivant : 000C32SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana.
Auteurs : Leigh Peterson [États-Unis] ; Kavita Nanda ; Baafuor Kofi Opoku ; William Kwabena Ampofo ; Margaret Owusu-Amoako ; Andrew Yiadom Boakye ; Wes Rountree ; Amanda Troxler ; Rosalie Dominik ; Ronald Roddy ; Laneta DorflingerSource :
- PloS one [ 1932-6203 ] ; 2007.
Descripteurs français
- KwdFr :
- MESH :
- administration et posologie : Agents antiVIH.
- effets indésirables : Agents antiVIH.
- usage thérapeutique : Agents antiVIH, Infections à VIH.
- Administration par voie topique, Adulte, Femelle, Gels, Ghana, Humains, Infections à VIH, Mâle, Méthode en double aveugle, Placebo.
- Wicri :
- geographic : Ghana.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Anti-HIV Agents.
- chemical , adverse effects : Anti-HIV Agents.
- chemical , therapeutic use : Anti-HIV Agents.
- geographic : Ghana, Placebos.
- prevention & control : HIV Infections.
- transmission : HIV Infections.
- Administration, Topical, Adult, Double-Blind Method, Female, Gels, Humans, Male.
Abstract
The objective of this trial was to determine the effectiveness of 1.0% C31G (SAVVY) in preventing male-to-female vaginal transmission of HIV infection among women at high risk.
DOI: 10.1371/journal.pone.0001312
PubMed: 18091987
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000234
- to stream PubMed, to step Curation: 000234
- to stream PubMed, to step Checkpoint: 000234
- to stream Ncbi, to step Merge: 000266
- to stream Ncbi, to step Curation: 000266
- to stream Ncbi, to step Checkpoint: 000266
- to stream Main, to step Merge: 000C55
- to stream Main, to step Curation: 000C31
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana.</title><author><name sortKey="Peterson, Leigh" sort="Peterson, Leigh" uniqKey="Peterson L" first="Leigh" last="Peterson">Leigh Peterson</name><affiliation wicri:level="2"><nlm:affiliation>Family Health International, Durham, North Carolina, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Family Health International, Durham, North Carolina</wicri:regionArea><placeName><region type="state">Caroline du Nord</region></placeName></affiliation></author><author><name sortKey="Nanda, Kavita" sort="Nanda, Kavita" uniqKey="Nanda K" first="Kavita" last="Nanda">Kavita Nanda</name></author><author><name sortKey="Opoku, Baafuor Kofi" sort="Opoku, Baafuor Kofi" uniqKey="Opoku B" first="Baafuor Kofi" last="Opoku">Baafuor Kofi Opoku</name></author><author><name sortKey="Ampofo, William Kwabena" sort="Ampofo, William Kwabena" uniqKey="Ampofo W" first="William Kwabena" last="Ampofo">William Kwabena Ampofo</name></author><author><name sortKey="Owusu Amoako, Margaret" sort="Owusu Amoako, Margaret" uniqKey="Owusu Amoako M" first="Margaret" last="Owusu-Amoako">Margaret Owusu-Amoako</name></author><author><name sortKey="Boakye, Andrew Yiadom" sort="Boakye, Andrew Yiadom" uniqKey="Boakye A" first="Andrew Yiadom" last="Boakye">Andrew Yiadom Boakye</name></author><author><name sortKey="Rountree, Wes" sort="Rountree, Wes" uniqKey="Rountree W" first="Wes" last="Rountree">Wes Rountree</name></author><author><name sortKey="Troxler, Amanda" sort="Troxler, Amanda" uniqKey="Troxler A" first="Amanda" last="Troxler">Amanda Troxler</name></author><author><name sortKey="Dominik, Rosalie" sort="Dominik, Rosalie" uniqKey="Dominik R" first="Rosalie" last="Dominik">Rosalie Dominik</name></author><author><name sortKey="Roddy, Ronald" sort="Roddy, Ronald" uniqKey="Roddy R" first="Ronald" last="Roddy">Ronald Roddy</name></author><author><name sortKey="Dorflinger, Laneta" sort="Dorflinger, Laneta" uniqKey="Dorflinger L" first="Laneta" last="Dorflinger">Laneta Dorflinger</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:18091987</idno><idno type="pmid">18091987</idno><idno type="doi">10.1371/journal.pone.0001312</idno><idno type="wicri:Area/PubMed/Corpus">000234</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000234</idno><idno type="wicri:Area/PubMed/Curation">000234</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000234</idno><idno type="wicri:Area/PubMed/Checkpoint">000234</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000234</idno><idno type="wicri:Area/Ncbi/Merge">000266</idno><idno type="wicri:Area/Ncbi/Curation">000266</idno><idno type="wicri:Area/Ncbi/Checkpoint">000266</idno><idno type="wicri:Area/Main/Merge">000C55</idno><idno type="wicri:Area/Main/Curation">000C31</idno><idno type="wicri:Area/Main/Exploration">000C31</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana.</title><author><name sortKey="Peterson, Leigh" sort="Peterson, Leigh" uniqKey="Peterson L" first="Leigh" last="Peterson">Leigh Peterson</name><affiliation wicri:level="2"><nlm:affiliation>Family Health International, Durham, North Carolina, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Family Health International, Durham, North Carolina</wicri:regionArea><placeName><region type="state">Caroline du Nord</region></placeName></affiliation></author><author><name sortKey="Nanda, Kavita" sort="Nanda, Kavita" uniqKey="Nanda K" first="Kavita" last="Nanda">Kavita Nanda</name></author><author><name sortKey="Opoku, Baafuor Kofi" sort="Opoku, Baafuor Kofi" uniqKey="Opoku B" first="Baafuor Kofi" last="Opoku">Baafuor Kofi Opoku</name></author><author><name sortKey="Ampofo, William Kwabena" sort="Ampofo, William Kwabena" uniqKey="Ampofo W" first="William Kwabena" last="Ampofo">William Kwabena Ampofo</name></author><author><name sortKey="Owusu Amoako, Margaret" sort="Owusu Amoako, Margaret" uniqKey="Owusu Amoako M" first="Margaret" last="Owusu-Amoako">Margaret Owusu-Amoako</name></author><author><name sortKey="Boakye, Andrew Yiadom" sort="Boakye, Andrew Yiadom" uniqKey="Boakye A" first="Andrew Yiadom" last="Boakye">Andrew Yiadom Boakye</name></author><author><name sortKey="Rountree, Wes" sort="Rountree, Wes" uniqKey="Rountree W" first="Wes" last="Rountree">Wes Rountree</name></author><author><name sortKey="Troxler, Amanda" sort="Troxler, Amanda" uniqKey="Troxler A" first="Amanda" last="Troxler">Amanda Troxler</name></author><author><name sortKey="Dominik, Rosalie" sort="Dominik, Rosalie" uniqKey="Dominik R" first="Rosalie" last="Dominik">Rosalie Dominik</name></author><author><name sortKey="Roddy, Ronald" sort="Roddy, Ronald" uniqKey="Roddy R" first="Ronald" last="Roddy">Ronald Roddy</name></author><author><name sortKey="Dorflinger, Laneta" sort="Dorflinger, Laneta" uniqKey="Dorflinger L" first="Laneta" last="Dorflinger">Laneta Dorflinger</name></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Topical</term><term>Adult</term><term>Anti-HIV Agents (administration & dosage)</term><term>Anti-HIV Agents (adverse effects)</term><term>Anti-HIV Agents (therapeutic use)</term><term>Double-Blind Method</term><term>Female</term><term>Gels</term><term>Ghana</term><term>HIV Infections (prevention & control)</term><term>HIV Infections (transmission)</term><term>Humans</term><term>Male</term><term>Placebos</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Administration par voie topique</term><term>Adulte</term><term>Agents antiVIH (administration et posologie)</term><term>Agents antiVIH (effets indésirables)</term><term>Agents antiVIH (usage thérapeutique)</term><term>Femelle</term><term>Gels</term><term>Ghana</term><term>Humains</term><term>Infections à VIH ()</term><term>Infections à VIH (transmission)</term><term>Mâle</term><term>Méthode en double aveugle</term><term>Placebo</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-HIV Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anti-HIV Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-HIV Agents</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Ghana</term><term>Placebos</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Agents antiVIH</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Agents antiVIH</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Agents antiVIH</term><term>Infections à VIH</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Topical</term><term>Adult</term><term>Double-Blind Method</term><term>Female</term><term>Gels</term><term>Humans</term><term>Male</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Administration par voie topique</term><term>Adulte</term><term>Femelle</term><term>Gels</term><term>Ghana</term><term>Humains</term><term>Infections à VIH</term><term>Mâle</term><term>Méthode en double aveugle</term><term>Placebo</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The objective of this trial was to determine the effectiveness of 1.0% C31G (SAVVY) in preventing male-to-female vaginal transmission of HIV infection among women at high risk.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Caroline du Nord</li></region></list><tree><noCountry><name sortKey="Ampofo, William Kwabena" sort="Ampofo, William Kwabena" uniqKey="Ampofo W" first="William Kwabena" last="Ampofo">William Kwabena Ampofo</name><name sortKey="Boakye, Andrew Yiadom" sort="Boakye, Andrew Yiadom" uniqKey="Boakye A" first="Andrew Yiadom" last="Boakye">Andrew Yiadom Boakye</name><name sortKey="Dominik, Rosalie" sort="Dominik, Rosalie" uniqKey="Dominik R" first="Rosalie" last="Dominik">Rosalie Dominik</name><name sortKey="Dorflinger, Laneta" sort="Dorflinger, Laneta" uniqKey="Dorflinger L" first="Laneta" last="Dorflinger">Laneta Dorflinger</name><name sortKey="Nanda, Kavita" sort="Nanda, Kavita" uniqKey="Nanda K" first="Kavita" last="Nanda">Kavita Nanda</name><name sortKey="Opoku, Baafuor Kofi" sort="Opoku, Baafuor Kofi" uniqKey="Opoku B" first="Baafuor Kofi" last="Opoku">Baafuor Kofi Opoku</name><name sortKey="Owusu Amoako, Margaret" sort="Owusu Amoako, Margaret" uniqKey="Owusu Amoako M" first="Margaret" last="Owusu-Amoako">Margaret Owusu-Amoako</name><name sortKey="Roddy, Ronald" sort="Roddy, Ronald" uniqKey="Roddy R" first="Ronald" last="Roddy">Ronald Roddy</name><name sortKey="Rountree, Wes" sort="Rountree, Wes" uniqKey="Rountree W" first="Wes" last="Rountree">Wes Rountree</name><name sortKey="Troxler, Amanda" sort="Troxler, Amanda" uniqKey="Troxler A" first="Amanda" last="Troxler">Amanda Troxler</name></noCountry><country name="États-Unis"><region name="Caroline du Nord"><name sortKey="Peterson, Leigh" sort="Peterson, Leigh" uniqKey="Peterson L" first="Leigh" last="Peterson">Leigh Peterson</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C31 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000C31 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:18091987
|texte= SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:18091987" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |